Stroke prophylaxis in high-risk patients with atrial fibrillation: Rhythm vs. rate control strategy.

CONCLUSIONS: Anti-thrombotic prophylaxis in CHADS₂ ≥2 patients is different in subjects assigned to the Rhythm vs. the Rate control strategy, as well as reported reasons for warfarin non use. GPs do not know why warfarin is not used in a large percentage of cases, mainly in the rhythm control strategy group. Improving efforts should probably be differently tailored for patients assigned to the "rhythm" or the "rate" control strategy.
PMID: 23474251 [PubMed - as supplied by publisher]

Source: European Journal of Internal Medicine - March 5, 2013 Category: Internal Medicine Authors: Filippi A, Zoni-Berisso M, Ermini G, Landolina M, Brignoli O, D'Ambrosio G, Zingarini G, Pedrinazzi C Tags: Eur J Intern Med Source Type: research